Welcome to our dedicated page for ETHZilla news (Ticker: ETHZW), a resource for investors and traders seeking the latest updates and insights on ETHZilla stock.
Forum Markets, Inc. news covers corporate-status and capital-market updates for a Nasdaq-listed issuer that previously operated as ETHZilla Corporation and 180 Life Sciences Corp. Reported developments include ticker and brand changes, public warrant trading history, share repurchase updates, at-the-market equity financing activity, and amendments affecting preferred stock rights.
Company news has also included ETHZilla’s Ethereum treasury strategy, including Ether accumulation, external asset management, and on-chain yield-generation concepts tied to staking, lending, liquidity provisioning, and private agreements.
ETHZilla Corporation (NASDAQ: ETHZ), formerly 180 Life Sciences Corp. (NASDAQ: ATNF), announced a major rebranding and strategic shift to focus on Ethereum treasury operations. The company's stock will begin trading under the new ticker ETHZ on August 18, 2025.
The company has successfully raised $565 million through private placements, including a $425 million PIPE and $156.25 million convertible note offering. ETHZilla has already accumulated 94,675 ETH at an average price of $3,902.20, currently valued at approximately $419 million, with an additional $187 million in cash equivalents.
Electric Capital will serve as the external asset manager, implementing an on-chain yield generation program combining staking, lending, and liquidity provisioning. The private placement attracted over 60 institutional and crypto-native investors, including prominent Ethereum ecosystem leaders.